Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

GE Healthcare Scientist Paired with Cardiff MP to Share Insights on Cell Therapy, Science and Policy-Making

Published: Thursday, November 15, 2012
Last Updated: Thursday, November 15, 2012
Bookmark and Share
Dr. Michelle Janas from GE Healthcare Life Sciences visited Jenny Willott MP at the House of Commons for a “Week in Westminster” as part of a unique ‘pairing’ scheme run by the Royal Society.

Dr. Janas is a Lead Scientist at GE Healthcare’s laboratories in Cardiff, Wales, where she is part of the team pioneering new technologies for cell therapy.  During her visit, she shadowed Ms Willott MP to learn about her work.  She also attended a House of Commons Science and Technology Committee meeting and Prime Minister’s Question Time, and met with Professor Sir John Beddington, Government Chief Scientific Advisor.  The visit provided Dr. Janas with a behind-the-scenes insight into how science policy is formed as well as an understanding of the working life of an MP.  Under the pairing scheme, Ms Willott will make a reciprocal visit to GE Healthcare.
 
Cell therapy, the use of cells to replace damaged tissue or treat disease, has the potential to help millions of patients suffering from life-threatening and life-limiting diseases like cancer and heart disease. Very much at the cutting edge of medicine, the UK Government recently announced a £50m investment into a new cell therapy technology innovation centre. GE Healthcare has established a global Centre of Excellence for Cell Technology Research at its facility in Cardiff, Wales.
 
Dr. Janas said: “I believe scientists have a role to play in helping to make innovations like cell therapy a reality through engagement with politicians and policy makers. It is exciting to be sharing my scientific experience with Ms Willott MP and I’m keen to further my understanding of how science policy is developed and communicated to the wider community.”
 
Jenny Willott MP said: “From participating in the scheme before, I know how rewarding and helpful it is to gain a different perspective.  I look forward to learning about Dr. Janas’ work on cell therapy at her lab in Cardiff. I hope I will get a better understanding of how politics and research together can realise the potential of these new technologies to bring real benefits to patients.”
 
Sir Paul Nurse, President of the Royal Society said:  “We live in a world facing increasing challenges that can only be addressed with a clear understanding of science.  From climate change to influenza outbreaks, GM food to nuclear power, our MPs have to make decisions about complex issues that will affect the lives of all those in the UK and, in many cases, more widely throughout the world.  This means that MPs and scientists have a responsibility to engage with each other to get the best possible scientific advice into public policy making.”
 
The Royal Society’s MP-Scientist pairing scheme aims to build bridges between parliamentarians and some of the best scientists in the UK. It is an opportunity for MPs to become better informed about science issues and for scientists to understand how they can influence science policy. Over 200 pairs of scientists and MPs have taken part in the scheme since it was launched in 2001.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GE Healthcare Licenses CRISPR Gene Engineering Technology Patents
Agreement will drive bioscience research by enabling development of novel Dharmacon genome engineering toolsets.
Tuesday, December 09, 2014
GE Licenses CRISPR Gene Engineering Technology Patents From Broad Institute
Agreement will drive bioscience research by enabling development of novel Dharmacon genome engineering toolsets.
Thursday, December 04, 2014
GE Healthcare to Collaborate with GlaxoSmithKline on Commercial Oncology Testing
The collaboration aims to improve access to diagnostic testing for cancer patients by establishing a network of clinical laboratories to identify genetic mutations associated with different tumour types.
Tuesday, September 30, 2014
GE Healthcare to Invest $1 Billion in New Oncology Solutions
Expanding advanced cancer diagnostic and molecular imaging capabilities.
Saturday, September 17, 2011
GE Healthcare Appoints Kieran Murphy as Life Sciences CEO, Successor to Peter Ehrenheim
On 1 April 2011, Kieran Murphy will be promoted to succeed current Life Sciences President and CEO Peter Ehrenheim who will retire from GE after a transition period on July 31 2011.
Tuesday, February 22, 2011
IN Cell Image Competition 2009/2010 Voting Opens
Vote for your favorite image and receive a complementary 2010 calendar!
Tuesday, December 01, 2009
GE Launches $250 Million Healthymagination Fund
New equity investment fund to invest in high potential healthcare technology companies; Supports GE’s global Healthymagination initiative, focusing on cost, access and quality.
Monday, October 26, 2009
GE Healthcare Forms Strategic Alliance with FUJIFILM in Life Sciences
Under the alliance, Fujifilm will develop, manufacture and supply advanced biomolecular imaging systems to GE Healthcare.
Thursday, June 04, 2009
GE Healthcare Forms Strategic Alliance with FUJIFILM in Life Sciences
GE Healthcare announced that it has entered into a Strategic Alliance Agreement with FUJIFILM Corporation. Under the alliance, Fujifilm will develop, manufacture and supply advanced biomolecular imaging systems to GE Healthcare.
Thursday, May 28, 2009
Winners of GE Healthcare’s IN Cell Image Competition Announced
Each of the three winners, from Asia, Europe and North America, will be rewarded with a trip to New York City in March.
Wednesday, January 14, 2009
Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Toxin from Salmonid Fish has Potential to Treat Cancer
Researchers from the University of Freiburg decode molecular mechanism of fish pathogen.
Study Finds Non-Genetic Cancer Mechanism
Cancer can be caused solely by protein imbalances within cells, a study of ovarian cancer has found.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Tracking Breast Cancer Before it Grows
A team of scientists led by University of Saskatchewan researcher Saroj Kumar is using cutting-edge Canadian Light Source techniques to screen and treat breast cancer at its earliest changes.
DNA Damage Seen in Patients Undergoing CT Scanning
Along with the burgeoning use of advanced medical imaging tests over the past decade have come rising public health concerns about possible links between low-dose radiation and cancer.
The Mystery of the Instant Noodle Chromosomes
Researchers from the Lomonosov Moscow State University evaluated the benefits of placing the DNA on the principle of spaghetti.
Oxitec ‘Self-Limiting Gene’ Offers Hope for Controlling Invasive Moth
A new pesticide-free and environmentally-friendly way to control insect pests has moved ahead with the publication of results showing that Oxitec diamondback moths (DBM) with a ‘self-limiting gene’ can dramatically reduce populations of DBM.
Web App Helps Researchers Explore Cancer Genetics
Brown University computer scientists have developed a new interactive tool to help researchers and clinicians explore the genetic underpinnings of cancer.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!